抗体药物结合的未来通过比较各种特定部位结合的方法
Jeffrey Okojie1,2, Sarah McCollum2,3, Jared Barrott1,2
1Departments of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.
Discovery medicine
|December 7, 2023
概括
抗体与药物联合体 (ADC) 提供有效的癌症治疗,副作用较少. 特定站点的结合方法提高了ADC的稳定性和可重复性,而不是较旧的随机方法.
科学领域:
- 在瘤学瘤学.
- 生物结合化学 生物结合化学
- 制药科学 制药科学
背景情况:
- 瘤学研究优先考虑具有最小副作用的有效癌症治疗方法.
- 抗体-药物合物 (ADC) 是癌症治疗中一个有前途的治疗类.
- 目前的ADC疗法显示出有效性,但由于结合方法,它们在稳定性和可重复性方面面临挑战.
研究的目的:
- 审查与抗体药物结合剂 (ADC) 相关的成功和挑战.
- 在ADC生产中确定历史随机对联方法的局限性.
- 探索针对ADC的特定地点的结合技术的进步及其益处.
主要方法:
- 对抗体-药物结合物 (ADC) 开发和结合策略的现有文献的审查.
- 随机与特定站点的结合方法的比较分析.
- 讨论在ADC制造中特定地点的结合所带来的优势.
主要成果:
- 抗体-药物合物 (ADCs) 在瘤学中显示出显著的治疗潜力.
- 随机结合方法虽然在历史上被使用过,但存在稳定性和可重复性的问题.
- 特定地点的结合方法提供了更好的控制,导致更一致和更稳定的ADC.
结论:
- 特定站点的结合比ADC开发的随机方法有了显著的进步.
- 这些改进的方法对于提高抗体与药物合物的安全性和有效性概况至关重要.
- 对特定位点结合的进一步研究可能会推动向癌症治疗的创新.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.8K
09:06Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
21.0K
相关概念视频
Phase II Conjugation Reactions: Overview
212
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
212
Hybridoma Technology
14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
